跳至主要内容
临床试验/NCT05390164
NCT05390164Unknown不适用

Sensory Symptoms as an Early Manifestation of Active Vitiligo: a Case-control Clinical and Molecular Study

Cairo University0 个研究点目标入组 90 人开始时间: 2022年5月25日最近更新:
适应症

试验速览

阶段
不适用
入组人数
90
主要终点
Neuropeptide

研究概览

简要总结

This work aims to assess sensory symptoms in early active vitiligo patients (segmental, non-segmental, or mixed) and to measure 3 neuropeptides expression in their lesional skin [neuropeptide Y(NPY), calcitonin gene-related peptide (CGRP), and nerve growth factors (NGF)] to correlate neuropeptide levels, sensory symptoms, and functions, with criteria of disease activity and perceived stress scale.

详细描述

Study Design: Case-control study Population: 45 patients with active vitiligo and 45 patients with stable vitiligo

Inclusion criteria:

Age: 18 years old and older Sex: both sexes

Exclusion criteria:

Other hypopigmented diseases such as pityriasis alba, tinea versicolor, lichen sclerosis, post-inflammatory hyperpigmentation, and leprosy as excluded by lack of accentuation by wood's light examination. - Cases who received treatment (systemic or topical) in the last 3 months before sampling. - Neurological or other diseases that cause itching. - Medical history of DM, HTN, or other systemic diseases, history of associated autoimmune diseases.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Active and stable vitiligo

排除标准

  • Diabetic or other associated disease

结局指标

主要结局

Neuropeptide

时间窗: 3 months

laboratory test

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hagar El Sayed

Dr

Cairo University

相似试验